Skip to content

Drug interactions

Thioguanine + Ublituximab

Severity: Moderate

Thioguanine and Ublituximab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ublituximab causes B-cell depletion and thioguanine causes myelosuppression, so the combination may increase susceptibility to infections.

What this interaction means in plain words

Thioguanine and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Thioguanine belongs to Oncology; Ublituximab belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Additive immunosuppression from B-cell depletion and antimetabolite myelosuppression.

What to do

Monitor blood counts and for infection, and consider prophylaxis per local protocols.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Thioguanine and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Thioguanine with Ublituximab?

MediHelp rates the interaction as moderate. Thioguanine and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ublituximab causes B-cell depletion and thioguanine causes myelosuppression, so the combination may increase susceptibility to infections.

How serious is the interaction between Thioguanine and Ublituximab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for infection, and consider prophylaxis per local protocols.

What other medicines interact with Thioguanine?

MediHelp also lists interactions of Thioguanine with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Thioguanine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in